A2Z Cust2Mate Solutions Corp., a technology company, focuses on the development and commercialization of retail smart cart solutions for grocery stores and supermarkets in Israel and internationally. The company operates through three segments: Precision Metal Parts, Advanced Engineering, and Smart Carts. It offers Cust2Mate system, which incorporates a smart cart that automatically calculates the value of the customers purchases in their smart cart without having to unload and reload their purchases at a customer checkout point. The company also manufactures and sells precision metal parts; provides retail automation solutions; and develops Fuel Tank Inertia Capsule System technology (FTICS), a vehicle device cover for the military and civilian automotive industry. In addition, it provides maintenance services utilizing the application of advanced engineering capabilities to the military and security markets, as well as develops related products for the civilian and retail markets; container leasing services; and maintenance services for complex electronic systems and products. It serves its products to grocery stores, hardware stores, household essentials, do it yourself (DIY) retailers, discount stores, warehouse stores, convenience stores, drug stores, duty free shops, and similar outlets. The company was formerly known as A2Z Smart Technologies Corp. and changed its name to  A2Z Cust2Mate Solutions Corp. in August 2024. The company is headquartered in Vancouver, Canada.

A2Z Cust2Mate Solutions Corp.

Park National ( ($PRK) ) has issued an announcement. Park National Corporation has furnished an updated investor presentation for use with analysts...

Park National Updates Investor Presentation Under Regulation FD

The latest update is out from Aztek Teknoloji Urunleri Ticaret A.S. ( ($TR:AZTEK) ). Aztek Teknoloji Urunleri Ticaret A.S. has signed a distributio...

Aztek Teknoloji Becomes De Facto Exclusive Bose Distributor in Türkiye

In a report released today, Anthony Stoss from Craig-Hallum reiterated a Buy rating on Acacia Research, with a price target of $6.00. According to ...

Craig-Hallum Sticks to Its Buy Rating for Acacia Research (ACTG)

In a report released today, Marcus Dunford-Castro from Jefferies maintained a Hold rating on Akzo Nobel NV, with a price target of €55.00. Accordin...

Jefferies Reaffirms Their Hold Rating on Akzo Nobel NV (0A00)

Plaza Retail REIT ( ($TSE:PLZ.UN) ) just unveiled an update. Plaza Retail REIT reported solid second-quarter 2026 results, with funds from operatio...

Plaza Retail REIT Boosts Earnings and Tightens Payouts on Strong Q2

An announcement from PROG Holdings ( ($PRG) ) is now available. On August 5, 2026, PROG Holdings, Inc. announced that its Board of Directors declar...

PROG Holdings Declares Quarterly Cash Dividend to Shareholders

An announcement from AstroNova ( ($ALOT) ) is now available. On June 16, 2026, AstroNova, Inc. entered into a merger agreement with Orion Merger Pa...

AstroNova Merger Advances After Antitrust Clearance Achieved

Analysts have been eager to weigh in on the Healthcare sector with new ratings on COMPASS Pathways (CMPS), Geron (GERN) and Azenta (AZTA). COMPASS ...

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS), Geron (GERN) and Azenta (AZTA)

Austin, Texas, United States, August 5th, 2026, FinanceWire AZIO AI is building an integrated technology infrastructure platform focused on AI data...

Azio AI Holdings (NASDAQ: AZIO) Is ‘One to Watch’

Aygaz Anonim Sirketi ( ($TR:AYGAZ) ) has provided an update. Aygaz has disclosed a detailed assessment of its compliance with participation (Islami...

Aygaz Details Limited Alignment With Participation Finance Principles in 2026 H1

Ahlatci Dogal Gaz Dagitim Enerji ve Yatirim AS ( ($TR:AHGAZ) ) has provided an update. Ahlatcı Doğal Gaz Dağıtım Enerji ve Yatırım A.Ş. has been ac...

Ahlatcı Doğal Gaz Lifts Treasury Stake to 2.8% Through Ongoing Share Buy-Backs

Shares in British pharma giant AstraZeneca ($AZN) jumped about 5% on Wednesday morning while those in top U.S. biopharma company Bristol Myers ($BM...

No $400B Mega Merger? AstraZeneca Rises, Bristol Myers Falls as Report Denies Deal

In a report released today, from Wells Fargo maintained a Hold rating on Waters, with a price target of $400.00. In addition to Wells Fargo, Waters...

Wells Fargo Reaffirms Their Hold Rating on Waters (WAT)

Aygaz Anonim Sirketi ( ($TR:AYGAZ) ) just unveiled an announcement. Aygaz Anonim Sirketi released its summary consolidated financial statements for...

Aygaz Publishes Limited-Review Interim Financials for First Half of 2026

An update from Aygaz Anonim Sirketi ( ($TR:AYGAZ) ) is now available. Aygaz A.Ş. has released its consolidated interim operating report for the per...

Aygaz Details Operations and Capital Structure in 2026 Interim LPG Report

Aygaz Anonim Sirketi ( ($TR:AYGAZ) ) has provided an announcement. Aygaz Anonim Sirketi has approved its consolidated interim financial statements ...

Aygaz Board Confirms Compliance and Accuracy of 2026 Interim Financials

Aygaz Anonim Sirketi ( ($TR:AYGAZ) ) has provided an announcement. Aygaz Anonim Sirketi has released its consolidated financial statements for the ...

Aygaz Publishes 2026 Half-Year Results and Outlook

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca has launched a new Phase III study called Eluminate-3 to...

AstraZeneca’s Eluminate-3 Trial Targets New Diabetes Growth Path

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is running a clinical study called “An Open-label Study ...

AstraZeneca Advances Early Combo Study With AZD0780 and AZD4954, Signaling Steady Pipeline Progress

Naturelgaz Sanayi Ve Ticaret A.S. ( ($TR:NTGAZ) ) has provided an update. Naturelgaz Sanayi ve Ticaret A.S. operates in the energy sector, focusing...

Naturelgaz Reports Strong Compliance With Participation Finance Principles

Ahlatci Dogal Gaz Dagitim Enerji ve Yatirim AS ( ($TR:AHGAZ) ) has provided an update. Ahlatci Doğal Gaz Dağıtım Enerji ve Yatırım A.Ş. has been ac...

Ahlatci Natural Gas Steps Up Share Buy-Backs to Support Valuation

Wells Fargo analyst Mohit Bansal assigned a Buy rating to Jazz Pharmaceuticals yesterday and set a price target of $300.00. Bansal covers the Healt...

Jazz Pharmaceuticals (JAZZ) Receives a Buy from Wells Fargo

SharonAI Holdings ( ($SHAZ) ) has provided an update. On August 4, 2026, Sharon AI Holdings Inc. announced it had entered into a five-year cloud co...

SharonAI secures major five-year AI cloud contract

UBS analyst Matthew Weston maintained a Buy rating on AstraZeneca today and set a price target of p17,600.00. According to TipRanks, Weston is rank...

AstraZeneca (AZN) Receives a Buy from UBS

UBS analyst Andrei Condrea maintained a Buy rating on EBRO FOODS today and set a price target of €21.70. According to TipRanks, Condrea is ranked #...

UBS Keeps Their Buy Rating on EBRO FOODS (0NYH)

Antipa Minerals Limited ( ($AU:AZY) ) has provided an update. Antipa Minerals Limited has issued 84,524 new ordinary shares on 4 August 2026 follow...

Antipa Minerals Issues New Shares Following Option Exercise

Antipa Minerals Limited ( ($AU:AZY) ) has provided an announcement. Antipa Minerals Limited has applied for quotation of 84,524 new ordinary fully ...

Antipa Minerals Lists Additional Shares on ASX

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HealthStream (HSTM) and Jazz Pharmaceuticals (JAZZ) ...

Analysts Offer Insights on Healthcare Companies: HealthStream (HSTM) and Jazz Pharmaceuticals (JAZZ)

TransCode Therapeutics ( ($RNAZ) ) has shared an announcement. TransCode Therapeutics, Inc., which utilizes Series A and Series B Non-Voting Conver...

TransCode Therapeutics Updates Preferred Stock Governance Terms

AZZ ( ($AZZ) ) has issued an announcement. On August 3, 2026, AZZ Inc. appointed veteran human resources executive Rhonda Davenport as Chief Human ...

AZZ Appoints Rhonda Davenport as Chief HR Officer

Austin, Texas, United States, August 3rd, 2026, FinanceWire AZIO AI Holdings (NASDAQ:AZIO) announced it has executed a master services agreement wi...

AZIO AI Holdings (NASDAQ: AZIO) Signs AT&T Fiber Agreement for 500 MW Texas AI Campus

Naturelgaz Sanayi Ve Ticaret A.S. ( ($TR:NTGAZ) ) has shared an update. Naturelgaz Sanayi ve Ticaret A.Ş. has published its 2025 Sustainability Rep...

Naturelgaz Releases TSRS-Compliant, Assured 2025 Sustainability Report

Naturelgaz Sanayi Ve Ticaret A.S. ( ($TR:NTGAZ) ) has provided an announcement. Naturelgaz Sanayi ve Ticaret A.Ş. has closed its Çayırova Auto CNG ...

Naturelgaz Shutters Çayırova Auto CNG Facility as Lease Expires

Naturelgaz Sanayi Ve Ticaret A.S. ( ($TR:NTGAZ) ) has provided an update. Naturelgaz Sanayi ve Ticaret A.S. detailed the geographic spread of its b...

Naturelgaz Maps Out Wide CNG Facility Network Across Turkey

Naturelgaz Sanayi Ve Ticaret A.S. ( ($TR:NTGAZ) ) has issued an announcement. Naturelgaz Sanayi ve Ticaret A.Ş. and its subsidiary have released th...

Naturelgaz earns clean limited review on H1 2026 financials

The latest update is out from Naturelgaz Sanayi Ve Ticaret A.S. ( ($TR:NTGAZ) ). Naturelgaz Sanayi ve Ticaret A.Ş. has released its Board of Direct...

Naturelgaz Publishes Interim Activity Report Backed by Limited Audit Review

Naturelgaz Sanayi Ve Ticaret A.S. ( ($TR:NTGAZ) ) has shared an announcement. Naturelgaz Sanayi Ve Ticaret A.S. disclosed that its consolidated int...

Naturelgaz Affirms Accuracy of Interim 2026 Financial Statements

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca plc (AZN) is advancing a Phase I study titled “A Phase I...

AstraZeneca’s Elecoglipron Trial: Early Signals for a Future Oral Metabolic Franchise

An update from Ahlatci Dogal Gaz Dagitim Enerji ve Yatirim AS ( ($TR:AHGAZ) ) is now available. Ahlatci Doğal Gaz Dağıtım Enerji ve Yatırım A.Ş., a...

Ahlatci Natural Gas Steps Up Share Buy-Back to Support Valuation

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on AstraZeneca, with a price target of £160.00. According to Ti...

J.P. Morgan Sticks to Its Buy Rating for AstraZeneca (AZN)

Antipa Minerals Limited ( ($AU:AZY) ) has issued an update. Antipa Minerals has released an investor presentation outlining its strategic focus on ...

Antipa Reaffirms Minyari Dome Potential and JORC-Compliant Reporting

Antipa Minerals Limited ( ($AU:AZY) ) has provided an update. Antipa Minerals reported Phase 1 drilling results from the Minyari Gold-Copper Projec...

Antipa Minerals Strengthens Telfer-Style Targets with Tim’s Dome Drill Results

Ahlatci Dogal Gaz Dagitim Enerji ve Yatirim AS ( ($TR:AHGAZ) ) just unveiled an announcement. Ahlatci Doğal Gaz Dağıtım Enerji ve Yatırım A.Ş. has ...

Ahlatci Dogal Gaz Expands Share Buy-Back as Treasury Stake Nears 2.8%

Aztek Teknoloji Urunleri Ticaret A.S. ( ($TR:AZTEK) ) has shared an update. Aztek Teknoloji Urunleri Ticaret A.S. has received approval from the Ca...

Aztek Teknoloji Secures CMB Approval for TRY 2 Billion Domestic Debt Program

The latest update is out from Aztek Teknoloji Urunleri Ticaret A.S. ( ($TR:AZTEK) ). Aztek Teknoloji Urunleri Ticaret A.S. has secured approval fro...

Aztek Teknoloji Gains CMB Approval for TRY 2 Billion Debt Issuance

Aztek Teknoloji Urunleri Ticaret A.S. ( ($TR:AZTEK) ) has shared an update. Turkey’s headphone market saw revenues rise 32.5% in the first half of ...

Aztek Teknoloji Strengthens Grip on Turkey’s Booming Audio Market

There’s a lot to be optimistic about in the Industrial Goods sector as 3 analysts just weighed in on CNH Industrial (CNH), SPX (SPXC) and AZZ (AZZ)...

Wall Street Analysts Are Bullish on Top Industrial Goods Picks

KBW analyst Damon Delmonte maintained a Hold rating on Park National today and set a price target of $205.00. According to TipRanks, Delmonte is a ...

KBW Remains a Hold on Park National (PRK)

Azelis Group N.V. ( ($MX:AZEN) ) has shared an update. Azelis Group reported H1 2026 revenue of EUR 2.2bn, up 3.2% in constant currency, with modes...

Azelis Returns to Organic Growth in H1 2026 as Margins and ESG Profile Strengthen

UOB Kay Hian analyst John Cheong maintained a Hold rating on Aztech Global Ltd. today and set a price target of S$0.73. According to TipRanks, Cheo...

UOB Kay Hian Sticks to Their Hold Rating for Aztech Global Ltd. (8AZ)

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. The PETRICHOR study is a real-world project from AstraZeneca that tr...

AstraZeneca’s PETRICHOR Study Tracks Real‑World Upside for Tezepelumab in Sinus Disease

Altamin Limited ( ($AU:AZI) ) just unveiled an update. Altamin advanced the Lazio Project during the June quarter, completing technical workstreams...

Altamin Advances Lazio Geothermal Brines Project as EU-Aligned Strategy Takes Shape

In a report released today, from Macquarie maintained a Hold rating on Aurizon Holdings, with a price target of A$4.09. In addition to Macquarie, A...

Macquarie Sticks to Its Hold Rating for Aurizon Holdings (QRNNF)

An update from Antipa Minerals Limited ( ($AU:AZY) ) is now available. Antipa Minerals reported a significant upgrade to the Mineral Resource Estim...

Antipa boosts Minyari resources and ramps up drilling in WA Paterson Province

Deutsche Bank analyst Emmanuel Papadakis maintained a Sell rating on AstraZeneca today and set a price target of £115.00. According to TipRanks, Pa...

Deutsche Bank  Keeps Their Sell Rating on AstraZeneca (AZN)

In a report released today, Nathan Race from Piper Sandler maintained a Hold rating on Park National, with a price target of $189.00. Race covers t...

Piper Sandler Sticks to Its Hold Rating for Park National (PRK)

Barclays analyst Dan Levy maintained a Sell rating on Hertz Global today and set a price target of $1.00. According to TipRanks, Levy is a 3-star a...

Hertz Global (HTZ) Gets a Sell from Barclays

In a report released today, Rajan Sharma from Goldman Sachs maintained a Buy rating on AstraZeneca, with a price target of p16,070.00. Sharma cover...

Goldman Sachs Reaffirms Their Buy Rating on AstraZeneca (AZN)

Cazaly Resources Limited ( ($AU:CAZ) ) has provided an update. Cazaly Resources reported a strong June 2026 quarter marked by high-grade gold resul...

Cazaly Resources Confirms High-Grade Gold at Goongarrie and Advances Namibian Copper-REE Exploration

Park National ( ($PRK) ) just unveiled an announcement. On February 1, 2026, Park National completed the merger of First Citizens Bancshares, Inc. ...

Park National declares quarterly dividend amid profit growth

The latest update is out from Azelis Group N.V. ( ($MX:AZEN) ). Azelis Group NV has disclosed that UBS Group AG crossed the 3% transparency thresho...

UBS briefly crosses 3% transparency threshold in Azelis holdings

Jazz Pharmaceuticals ($JAZZ) announced an update on their ongoing clinical study. Jazz Eyes Adult LGS Opportunity With New CBD Study. Jazz Pharmace...

Jazz Pharmaceuticals Targets Adult LGS Growth With New Cannabidiol Dosing Study

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca’s new MONTEROSA study tracks real world use of its STRID...

AstraZeneca’s MONTEROSA Study Tracks Real World Outcomes for STRIDE in Liver Cancer

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca’s phase 1 PECHORA study, officially titled “A Phase 1, Open-la...

AstraZeneca’s AZD2389 Liver Fibrosis Study Reaches Key Early Milestone

The latest announcement is out from SharonAI Holdings ( ($SHAZ) ). On July 22, 2026, SharonAI Holdings announced a planned chief financial officer ...

SharonAI Holdings Announces Strategic CFO Leadership Transition

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on UniCredit SpA (UNCFF), Lazard (LAZ) and Bread Finan...

Analysts Offer Insights on Financial Companies: UniCredit SpA (OtherUNCFF), Lazard (LAZ) and Bread Financial Holdings (BFH)

UBS analyst Michael Brown maintained a Hold rating on Lazard today and set a price target of $44.00. Brown covers the Financial sector, focusing on...

Lazard (LAZ) Gets a Hold from UBS

Drugs giant AstraZeneca ($AZN) is set to report its Q2 earnings next week – July 27. Let’s look at what investors should expect. The company’s shar...

AstraZeneca Reports Q2 Earnings Next Week. What Investors Should Expect.

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Pinnacle Financial Partners (PNFP), Dime Community ...

Analysts Conflicted on These Financial Names: Pinnacle Financial Partners (PNFP), Dime Community Bancshares (DCOM) and Lazard (LAZ)

Jazz Pharmaceuticals ( ($JAZZ) ) has issued an update. At its July 23, 2026 annual general meeting in Dublin, Jazz Pharmaceuticals’ shareholders el...

Jazz Pharmaceuticals Shareholders Reaffirm Board and Governance Plans

Hertz Global ( ($HTZ) ) has issued an announcement. On June 29, 2026, The Hertz Corporation issued $350 million of 6.75% Exchangeable Senior First-...

Hertz Global adjusts public warrant terms after new notes

In a report released today, Virginie Boucher-Ferte from Deutsche Bank maintained a Hold rating on Akzo Nobel NV, with a price target of €60.00. Acc...

Deutsche Bank  Sticks to Its Hold Rating for Akzo Nobel NV (0A00)

In a report released yesterday, Eve Burstein from Bernstein maintained a Buy rating on Waters, with a price target of $435.00. The company’s shares...

Bernstein Sticks to Their Buy Rating for Waters (WAT)

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca’s new DEBATE study tracks Greek patients with chronic si...

AstraZeneca’s DEBATE Study Signals Long‑Term Bet on Precision Sinus Care

Capgemini SE ( ($FR:CAP) ) has provided an announcement. Capgemini disclosed a series of share buyback transactions carried out between July 13 and...

Capgemini Steps Up Share Buybacks Across European Markets

In a report released today, James Hooper from Bernstein maintained a Hold rating on Akzo Nobel NV, with a price target of €60.00. According to TipR...

Bernstein Remains a Hold on Akzo Nobel NV (0A00)

Audience Analytics Limited ( ($SG:1AZ) ) has issued an update. Audience Analytics Limited has provided an update on how it has deployed the net pro...

Audience Analytics details deployment of IPO proceeds and expansion investments

In a report released today, Michael Leuchten from Jefferies maintained a Buy rating on AstraZeneca, with a price target of £175.00. According to Ti...

Jefferies Sticks to Its Buy Rating for AstraZeneca (AZN)

Goldman Sachs analyst maintained a Buy rating on Azzas 2154 SA today and set a price target of BRL30.00. Azzas 2154 SA has an analyst consensus of ...

Goldman Sachs Remains a Buy on Azzas 2154 SA (AZZA3)

In a report released on July 20, Sinclair Currie from MA Financial Group maintained a Buy rating on Catapult Group International, with a price targ...

MA Financial Group Reaffirms Their Buy Rating on Catapult Group International (CAZGF)

Antipa Minerals Limited ( ($AU:AZY) ) has shared an update. Antipa Minerals Limited has issued 163,382 new ordinary shares on 22 July 2026 followin...

Antipa Minerals Issues New Shares Following Option Exercises

Antipa Minerals Limited ( ($AU:AZY) ) has provided an announcement. Antipa Minerals Limited has lodged an application with the ASX for quotation of...

Antipa Minerals Adds 163,382 New Shares to ASX Quotation

Aurizon Holdings ( ($AU:AZJ) ) has shared an announcement. Aurizon Holdings has scheduled the release of its FY2026 financial results for Monday, 1...

Aurizon Sets Date for FY2026 Results and Investor Briefing

The latest announcement is out from Antipa Minerals Limited ( ($AU:AZY) ). Antipa Minerals has released an investor-focused document highlighting i...

Antipa Minerals Reaffirms Minyari Dome Development Potential in Investor Update

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study titled “A Multicenter Non-interventional Single-arm Retrospectiv...

AstraZeneca Halts Russian NMOSD Study: What It Means for AZN Investors

J.P. Morgan analyst Richard Vosser maintained a Buy rating on AstraZeneca today and set a price target of £123.80. According to TipRanks, Vosser is...

J.P. Morgan Sticks to Their Buy Rating for AstraZeneca (AZN)

TransCode Therapeutics ( ($RNAZ) ) has shared an update. On July 20, 2026, TransCode Therapeutics held its 2026 Annual Meeting of Stockholders, whe...

TransCode Therapeutics Shareholders Approve Key Capital Measures

Jazz Pharmaceuticals ($JAZZ) announced an update on their ongoing clinical study. Jazz Pharmaceuticals is running a Phase 2 study called “A Phase 2...

Jazz Targets Lung Cancer Growth With New Lurbinectedin–Durvalumab Trial

AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca has completed a mid-stage study testing AZD6234 for people liv...

AstraZeneca’s AZD6234 Obesity Trial Reaches Key Milestone, Raising New Market Hopes

Analysts are intrested in these 5 stocks: ( ($JAZZ) ), ( ($AAPL) ), ( ($AEP) ), ( ($MCO) ) and ( ($MMM) ). Here is a breakdown of their recent


Apple, Jazz, Moody’s, AEP, 3M Trending With Analysts

An announcement from TransCode Therapeutics ( ($RNAZ) ) is now available. On July 16, 2026, TransCode Therapeutics, Inc. amended and restated the c...

TransCode Therapeutics Updates Preferred Stock Ownership Limits

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca (AZN) has launched EvoPAR-Prostate05, a Phase III study ...

AstraZeneca’s New Saruparib Trial Targets Next Wave of Prostate Cancer Growth

AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. This phase 2 study, officially titled “A Phase 2, Open-Label Study t...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AZ	$6.22	+4.01%	176.49K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AZ	$6.22	+4.0%	176.49K
3
4
5
6

AZ

AZ

Get A2Z Cust2Mate Solutions Corp. Data in Excel

Get A2Z Cust2Mate Solutions Corp. Data in Excel